Compared to healthy controls and bacterial pneumonia patients, we observed elevated percentages of CD38+HLA-DR+ T cells in COVID-19 cases (0.94%, 2.16% vs. 10.01%, respectively, p < 0.001) (Figures 1D, E). The gene discussed is CD38; the disease is COVID-19.